Endogenous ADP-ribosylation in human platelets

Biochem Biophys Res Commun. 1988 Dec 30;157(3):1323-8. doi: 10.1016/s0006-291x(88)81019-2.

Abstract

We have studied ADP-ribosyltransferase activity in platelet cytosol and electropermeabilized platelets. Cytosolic activity causes ADP-ribosylation or of a 37 kDa protein that is activated by increasing the concentration of potassium phosphate. ADP-ribosylation is inhibited by thiol reagents, an effect partially reversed by cholera toxin. In electropermeabilized platelets incubated with [alpha-32P]NAD, the 37 kDa protein is also ADP-ribosylated as are other proteins and albumin. Under these conditions, ADP-ribosylation is partially inhibited by nicotinamide. This experimental design could be used to determine the effect of cell agonists on endogenous ADP-ribosylation of proteins.

MeSH terms

  • Adenosine Diphosphate Ribose / blood*
  • Blood Platelets / enzymology*
  • Cholera Toxin / pharmacology
  • Chromatography, High Pressure Liquid
  • Cytosol / enzymology
  • Dithiothreitol / pharmacology
  • Enzyme Activation / drug effects
  • Humans
  • Kinetics
  • Magnesium / pharmacology
  • NAD / metabolism
  • Pertussis Toxin
  • Phosphates / pharmacology
  • Poly(ADP-ribose) Polymerases / blood*
  • Potassium / pharmacology
  • Potassium Compounds*
  • Serum Albumin / metabolism
  • Virulence Factors, Bordetella / pharmacology

Substances

  • Phosphates
  • Potassium Compounds
  • Serum Albumin
  • Virulence Factors, Bordetella
  • NAD
  • Adenosine Diphosphate Ribose
  • Cholera Toxin
  • potassium phosphate
  • Poly(ADP-ribose) Polymerases
  • Pertussis Toxin
  • Magnesium
  • Potassium
  • Dithiothreitol